Aquatic veterinarians are expected to use all therapeutic agents, including antimicrobials, judiciously. Judicious use of antimicrobials for aquatic animals is necessary to restore aquatic animal health, protect the economic livelihood of commercial facilities, ensure the continued production of foods of animal origin, minimize development of antimicrobial resistance in animal pathogens, minimize development of antimicrobial resistance in human pathogens, and minimize the shedding of zoonotic pathogens into the environment and potentially into the food chain.
Appropriate disease prevention through effective vaccination is likely to reduce the incidence of disease and subsequent need for antimicrobial treatment. When there is an increased disease incidence, efforts to identify and correct immunosuppressive factors should be implemented. High-quality nutrition is of paramount importance and will provide general as well as immune-related health benefits for all life stages. Optimal nutrition can lead to a reduction in morbidity and mortality rates with a consequent decrease in the need for antimicrobial treatment. Water source quality should be evaluated, including an assessment of the potential disease transmission risk from feral populations and the related need for biosecurity measures to protect captive populations. This will help to prevent the introduction of additional pathogenic microorganisms that could cause diseases requiring antimicrobial treatment. Veterinarians should work closely with other aquatic animal health experts employed at the facility in the design and implementation of health management programs.
The veterinarian must adhere to the following:
Be either the person responsible for diagnosis of disease conditions in an aquatic animal facility or be working directly with an aquatic animal health professional at the facility.
Be available for questions or concerns following treatment with antimicrobial drugs.
Accept responsibility for health care of the aquatic animals on that facility.
Have familiarity with the facility through previous visits to the premises.
Under these circumstances, the veterinarian will be able to make a recommendation on appropriate antimicrobial drug treatment to minimize the development of antimicrobial resistance. Veterinarians prescribing, dispensing, or administering antimicrobials to aquatic animals should use the services of unbiased and reputable sources (eg, Food Animal Residue Avoidance Databank) to provide scientifically sound withdrawal times for food animal producers.
Antimicrobial resistance and human safety concerns, including human pathogen antimicrobial resistance and food-borne transmission of antimicrobial-resistant microorganisms or resistance determinants, are discussed at numerous regional, state, and national meetings every year. At least some portion of the required continuing education hours should be received on the topic of antimicrobial susceptibility of animal and potential zoonotic pathogens. Material accessible from reliable sources such as the FDA CVM, FARAD, and AVMA, and from the many available additional sources of professional information, should be incorporated into treatment considerations and recommendations. Many aspects of aquatic animal health management, including nutrition and immunology, are topics of active research. Veterinarians should stay current in their knowledge of this research, in the interest of developing effective disease control programs.
Records and observations on individual animals or within populations, such as ponds, tanks, pens, and raceways within a veterinarian's area of practice, may be very helpful in developing antimicrobial treatment recommendations. Historical diagnostic material obtained from postmortem and moribund aquatic animal examinations may also be helpful. Diagnostic data reports are a useful measure of changes in pathogen susceptibility patterns, although antimicrobial susceptibility profiles may be skewed (perhaps due to prior therapy). The status of the originating facility should be considered when establishing a diagnosis in disease outbreaks and when selecting a treatment protocol. Proven biosecurity measures should be implemented when aquatic animals are introduced to a facility to reduce the need for antimicrobial therapy.
The product label recommendations are established through sound scientific data. Veterinarians should follow the label instructions. Furthermore, the goal of therapy should be to reduce aquatic animal mortality rate and minimize disease recurrence. Veterinarians should strive for the lowest dosage and appropriate frequency and duration of treatment that achieves these goals. Veterinarians should rely on previous medical records and valid published information to support clinical judgments on the proper time to discontinue therapy. The antimicrobial drug label may require specific waste handling or may limit the concentration allowed in production facility effluent water. The veterinarian should assure that the antimicrobial-containing waste or effluent is handled according to the product label directions. Also, before authorizing antimicrobial administration, the veterinarian should assure that the production facility complies with appropriate federal, state, and local laws and regulations (eg, National Pollutant Discharge Elimination System permits) applicable to antimicrobial use and discharge. Withdrawal times in food animals should also be monitored for compliance.
When this information is combined with the clinical and laboratory information, prudent and judicious antimicrobial use decisions are possible. The label dose, route, frequency, and duration should be followed except where extralabel drug use is necessary and falls within applicable laws, regulations, and policies. Familiarity with extralabel drug use requirements is essential given the limited availability of approved antimicrobial drugs for aquatic animal use.
Specific outcome criteria prevent unnecessarily long therapy and indicate when the current therapy is ineffective. A timeline for expected results should be included in the treatment protocol.
If the specific outcome criteria are not being met within the expected timeline, the diagnosis and treatment protocol should be reevaluated by the veterinarian.
This will provide information on changes in pathogens in the population and indications of antimicrobial resistance development by the pathogens.
In clinical situations, the boundary between a narrow and broad spectrum of activity may be difficult to determine. Spectrum of activity will vary depending upon the bacteria affected by the antimicrobial drug and the treatment regimen chosen. Despite the difficulty in confining antimicrobial use to a narrow spectrum of activity, resistance to antimicrobials should be minimized by selecting an antimicrobial with a narrow spectrum of activity whenever possible. Aquatic animal veterinarians presently have access to a limited armamentarium of antimicrobials. However, this situation may change as new products are developed and approved. Veterinarians need to be attuned to the potential for change.
Antimicrobials that are of lesser importance in human medicine should be chosen when considering extralabel use of newer-generation antimicrobials. This is of particular concern if the drug is in the same class as a human antimicrobial that may be the primary or sole treatment for a human infection. New antimicrobials should be reserved for cases that can be predicted to be refractory to other therapies and should be used according to label directions or extralabel drug use regulations.
The veterinarian should work with clients to ensure that appropriate diagnostic procedures are in place to evaluate disease causation and initiate the appropriate antimicrobial therapy when indicated.
Each drug held at a client's facility should be properly labeled, stored in a secure location at the proper temperature, used according to instructions before its expiration date, and appropriately disposed of if past the expiration date on the drug label.
The amount of a particular antimicrobial prescribed or written in a veterinary feed directive should be consistent with the diagnosed disease and treatment requirements. If the antimicrobial is not dispensed by the veterinarian, then good communication between the veterinarian, animal producer, feed mill, and pharmaceutical distributor is essential. This communication needs to be coupled with the appropriate prescription or veterinary feed directive and correct medicated feed labeling to ensure proper antimicrobial usage. The prescribing veterinarian should seek to review or receive copies of invoices of scripted antimicrobial purchases to ensure that appropriate quantities are being purchased for use.
The veterinarian should ensure that labels are adequate to instruct facility personnel on the correct use of antimicrobials. The veterinarian should provide training to facility personnel on proper antimicrobial administration.
Veterinarians are encouraged to work with clients to develop written standard operating procedures for initiating disease diagnostic activities and implementing treatment. Those protocols should include specific procedures to follow when administering antimicrobials at aquatic animal facilities.
The aquatic veterinarian should also follow the principles of not using combination antimicrobial therapy unless there is information to show that this decreases or suppresses target organism resistance development, considering that there are no scientific data currently available to indicate that combination antibacterial therapy is beneficial with the few antimicrobials labeled for use in aquatic animals.
2016 American Veterinary Medical Association